Clay Mathile – Startup Investor Profile

Clay Mathile is an Angel Investor with an exemplary entrepreneurial and executive track record. He became a major investor in Riverain Medical and ooVoo, among others. Mathile is heavily invested in Ensequence and is also focused on philanthropic endeavors. He is the chairman and CEO of The Mathile Institute for the Advancement of Human Nutrition and the founder of Aileron, which supports the development of privately held businesses. His partnership and collaboration styles emphasize a values-driven approach, focusing on customers, culture, products, and people, with a commitment to quality and integrity in business.

Location: Dayton, Ohio, United States

Country: United States of America

Investment Regions: MENA, NA

Investment Stages: pre-seed, seed

Website:

AI Reasoning: Sources indicate Clay Mathile died in August 2023 and his most recent public activity referenced was an honorary doctorate in May 2023; no investment activity found after his death. The last known investments (e.g., ooVoo, Riverain Medical, Ensequence) date well before Aug 2023. Using the given date, his last investment occurred more than 12 months prior, so classify as low-active.

Low Activity – Only known angel investments more than 12 months ago.

Active – Known angel investments between the last 12 and 6 months.

Very Active – Known angel investments in the last 6 months.